BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28551713)

  • 1. Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.
    Passamonti L; Luijten M; Ziauddeen H; Coyle-Gilchrist ITS; Rittman T; Brain SAE; Regenthal R; Franken IHA; Sahakian BJ; Bullmore ET; Robbins TW; Ersche KD
    Psychopharmacology (Berl); 2017 Aug; 234(15):2289-2297. PubMed ID: 28551713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute methylphenidate administration reduces cocaine-cue attentional bias.
    Alcorn JL; Strickland JC; Lile JA; Stoops WW; Rush CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109974. PubMed ID: 32454161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomoxetine restores the response inhibition network in Parkinson's disease.
    Rae CL; Nombela C; Rodríguez PV; Ye Z; Hughes LE; Jones PS; Ham T; Rittman T; Coyle-Gilchrist I; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
    Brain; 2016 Aug; 139(Pt 8):2235-48. PubMed ID: 27343257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol Administration Increases Cocaine Craving But Not Cocaine Cue Attentional Bias.
    Marks KR; Pike E; Stoops WW; Rush CR
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1823-31. PubMed ID: 26331880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of atomoxetine in combination with intravenous cocaine in cocaine-experienced participants.
    Cantilena L; Kahn R; Duncan CC; Li SH; Anderson A; Elkashef A
    J Addict Med; 2012 Dec; 6(4):265-73. PubMed ID: 22987022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alcohol preload on attentional bias towards cocaine-related cues.
    Montgomery C; Field M; Atkinson AM; Cole JC; Goudie AJ; Sumnall HR
    Psychopharmacology (Berl); 2010 Jun; 210(3):365-75. PubMed ID: 20352412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I can't get it off my mind: Attentional bias in former and current cocaine addiction.
    Smith P; N'Diaye K; Fortias M; Mallet L; Vorspan F
    J Psychopharmacol; 2020 Nov; 34(11):1218-1225. PubMed ID: 32842838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefrontal Cortex Activation and Stopping Performance Underlie the Beneficial Effects of Atomoxetine on Response Inhibition in Healthy Volunteers and Those With Cocaine Use Disorder.
    Zhukovsky P; Morein-Zamir S; Ziauddeen H; Fernandez-Egea E; Meng C; Regenthal R; Sahakian BJ; Bullmore ET; Robbins TW; Dalley JW; Ersche KD
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Nov; 7(11):1116-1126. PubMed ID: 34508901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects.
    DeVito EE; Herman AI; Konkus NS; Zhang H; Sofuoglu M
    Pharmacol Biochem Behav; 2017 Aug; 159():55-61. PubMed ID: 28716656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder.
    Chamberlain SR; Del Campo N; Dowson J; Müller U; Clark L; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2007 Nov; 62(9):977-84. PubMed ID: 17644072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial.
    Nuijten M; Blanken P; Van den Brink W; Goudriaan AE; Hendriks VM
    J Psychopharmacol; 2016 Jul; 30(7):616-26. PubMed ID: 27147591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease.
    Borchert RJ; Rittman T; Passamonti L; Ye Z; Sami S; Jones SP; Nombela C; Vázquez Rodríguez P; Vatansever D; Rae CL; Hughes LE; Robbins TW; Rowe JB
    Neuropsychopharmacology; 2016 Jul; 41(8):2171-7. PubMed ID: 26837463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orbitofrontal cortex is selectively activated in a primate model of attentional bias to cocaine cues.
    Baeg E; Jedema HP; Bradberry CW
    Neuropsychopharmacology; 2020 Mar; 45(4):675-682. PubMed ID: 31461747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study.
    Hall D; Lawn W; Ofori S; Trinci K; Borissova A; Mokrysz C; Petrilli K; Bloomfield MAP; Wall MB; Freeman TP; Curran HV
    Psychopharmacology (Berl); 2024 Jun; 241(6):1125-1134. PubMed ID: 38416223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease.
    O'Callaghan C; Hezemans FH; Ye R; Rua C; Jones PS; Murley AG; Holland N; Regenthal R; Tsvetanov KA; Wolpe N; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
    Brain; 2021 Sep; 144(8):2513-2526. PubMed ID: 33783470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-saccade error rates as a measure of attentional bias in cocaine dependent subjects.
    Dias NR; Schmitz JM; Rathnayaka N; Red SD; Sereno AB; Moeller FG; Lane SD
    Behav Brain Res; 2015 Oct; 292():493-9. PubMed ID: 26164486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial.
    Walsh SL; Middleton LS; Wong CJ; Nuzzo PA; Campbell CL; Rush CR; Lofwall MR
    Drug Alcohol Depend; 2013 Jun; 130(1-3):150-7. PubMed ID: 23200303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of escitalopram on attentional bias to cocaine-related stimuli and inhibitory control in cocaine-dependent subjects.
    Liu S; Lane SD; Schmitz JM; Cunningham KA; John VP; Moeller FG
    J Psychopharmacol; 2013 Sep; 27(9):801-7. PubMed ID: 23761390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.
    Baskin BM; Nic Dhonnchadha BÁ; Dwoskin LP; Kantak KM
    Psychopharmacology (Berl); 2017 Oct; 234(19):2897-2909. PubMed ID: 28730282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex.
    Newman LA; Darling J; McGaughy J
    Psychopharmacology (Berl); 2008 Sep; 200(1):39-50. PubMed ID: 18568443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.